I agree. Marketing is a good way for pushing products that have no lab tested proof. So the brand power will be important.
I'm a believer of the saying: good management makes good companies. In Acuvax, we have most of the directors having investment backgrounds. You'd expect directors with good lab/chemical engineering experience would be ideal. But thinking optimistically:
-We now have a product to invest in
-We have investment/mining/accounting/resourcing background directors. These industries sectors rely alot on brand power for people to invest in them or purpose their products.
-Referring to the above, hopefully these guys know how to make a sale!
Looking at it negatively:
-directors do not have any experience selling pharmaceutical products.
-given enough sales do take place as a result of a general interest (ie not high to cause a company maker, not low enough to cause bankruptcy); share price does not move...like the most of this year.
I remain optimistic with my small holding in acu. Small holding, but big gain %'s if ANYTHING ever happens in this quiet neighborhood...
- Forums
- ASX - By Stock
- Ann: Proposed BioHealth Acquisition
I agree. Marketing is a good way for pushing products that have...
Featured News
Add PC1 (ASX) to my watchlist
Currently unlisted public company.
The Watchlist
1CG
ONE CLICK GROUP LIMITED
Mark Waller, MD
Mark Waller
MD
Previous Video
Next Video
SPONSORED BY The Market Online